Latest News & Features
Americas
A US appeals court has for the second time invalidated a patent covering pharmaceutical company Teva’s multiple sclerosis drug Copaxone. 22 June 2015
Big Pharma
Law firm Pinsent Masons has expanded its Munich office with the hire of Marc Holtorf as partner. 22 June 2015
Americas
US law firm Honigman Miller Schwartz and Cohn has hired two intellectual property lawyers as partners. 19 June 2015
Americas
Recent patent decisions in the life sciences sector are leading biotechnology companies to seek protection for their innovations by using alternatives to patents, with trade secrets the most viable, the BIO International Convention has heard. 18 June 2015
Americas
On day three of the BIO International Convention, LSIPR spoke to Kevin Noonan and Donald Zuhn, partners at law firm McDonnell Boehnen Hulbert & Berghoff and authors of the Patent Docs blog, about the possible impact of the Federal Circuit’s Ariosa v Sequenom decision on the life sciences industry. 18 June 2015
Americas
Scott Kamholz, a former judge at the Patent Trial and Appeal Board, recently returned to law firm Foley Hoag as partner. LSIPR spoke to him at this year’s BIO International Convention, where he explained why the inter-partes review is not a “death squad” for patents. 18 June 2015
Americas
Australia could be going down the road of no longer allowing gene patents, New Zealand-based patent lawyer David Nowak said at the BIO International Convention yesterday. 18 June 2015
Americas
Philip Johnson, Johnson & Johnson’s senior vice president of intellectual property and policy, told the BIO International Convention yesterday that uncertainty around patent eligibility of inventions is a “silent killer of innovation”. 18 June 2015
Americas
The Transatlantic Trade and Investment Partnership has the potential to reinforce intellectual property as a driver of innovation, said Washington, DC-based former lawyer Jennifer Hillman at the BIO International Convention on Tuesday. 17 June 2015
Americas
Jacqueline Wright Bonilla, an administrative judge at the US Patent and Trademark Office, has told the BIO International Convention that despite inter partes review proceedings appearing to favour petitioners, the USPTO is not pro-petitioner, patent owner or even IPR. 17 June 2015